Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer

Human epidermal growth factor receptor 2 (HER2) gene amplification in circulating tumor cells (CTCs) and disseminated tumor cells (DTCs) might be useful for modifying Herceptin therapy in breast cancer. In the process of investigating the utility of a microfluidic platform for detecting HER2 gene am...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnamurthy, Savitri, Bischoff, Farideh, Ann Mayer, Julie, Wong, Karina, Pham, Tam, Kuerer, Henry, Lodhi, Ashutosh, Bhattacharyya, Anirban, Hall, Carolyn, Lucci, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639661/
https://www.ncbi.nlm.nih.gov/pubmed/23634290
http://dx.doi.org/10.1002/cam4.70

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639661/
https://www.ncbi.nlm.nih.gov/pubmed/23634290
http://dx.doi.org/10.1002/cam4.70

Ejemplares similares